Beverly Hills, CA -- May 23, 2016 -- InvestorsHub NewsWire -- VitaCig, Inc. (OTC PINK: VTCQ), a technology company that is harnessing mobile vaporization technology for multiple delivery applications, as well as a leader in the development, marketing, and sale of ultra-pure CBD Tinctures, Edibles, Concentrates, and E-Liquids is pleased to announce further international expansion by securing a three year distribution agreement for Japan with a minimum purchase of $1.3M over the next three years.
Fresh off the heels of closing a $1.35M three year contract for China, VitaCig Inc. has closed yet again another lucrative exclusive international contract, this time for Japan.  A country highly recognized as having abnormally high rate of smoking. 

Glenn Kassell CEO comments, “I am extremely pleased to announce our agreement with Mr. Masayuki Eshika, CEO of Crearesse Inc., along with International Merchandise Consultants for the distribution and sale of our premier line of products in Japan. Focusing on both national and international expansion will be a key path forward for long term growth and success.  It is important for shareholders and the investment community to understand that this aggressive focus on international markets is not by accident. Having been expecting new Federal e-cig regulations to come down for some time, our team has been relentless in pursuing and securing international contracts, where e-cig regulation may not be as harsh. With our company now offering both nicotine and non-nicotine based products, it is important that our team establish distribution channels for both product lines. Our commitment to international development will ensure our business opportunities stay strong.”

New VitaCig International Partner Mr. Masayuki Eshika comments, “I am extremely excited about the new partnership with VitaCig Inc., the maker of the original Vitamin Vaporizer. “I am honored to have the ability to offer a healthier alternative to tar and tobacco based products, and taking into consideration the overwhelming initial interest, we are looking forward to a very lucrative partnership with the team at VitaCig.”

VitaCig continues to expand its intellectual property on a global basis as it continues to strengthen its brand worldwide.
The fact that the 
VitaCig® was the very "first" and "original", vitamin vaporizer to market, offers our international distributors the marketing and branding edge they need to comptete against similar branded products now available on the market place. VitaCig is currently in negotiations to lock in similar deals for its VitaCig brand and products for India, UAE, Kuwait, South Africa, Canada, Asia, Latin America, and U.S. territories. In addition, our partner in Europe continues product expansion throughout EU, including new markets like Switzerland, Australia, and Spain, expected to come online during the second quarter of our fiscal year.

Lastly, the all new VitaCig18® Nicotine Edition and new VitaCig® Succulent Strawberry flavor is now available for pre-sale discount on our http://www.vitacig.org/ website. 
Stay tuned for future updates!
 About VitaCig, Inc.
 
VitaCig, Inc. (OTC PINK: VTCQ) is a technology company harnessing mobile vaporization technology for medical delivery applications. The company owns, manufactures, and distributes the VitaCig®, a nicotine-free device. As well as a leader in the development, marketing, and sale of ultra-pure CBD Oil tinctures, Edibles, and E-Liquids.
The company's products are sold online at: www.mcig.org, www.vitacbd.com, www.vitacig.org, or through affiliate websites and select brick and mortar locations.
Safe Harbor Statement
 
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.
Contact:
VitaCig, Inc.
Glenn Kassel
CEO
Glenn@vitacig.org
 

Omni Health (CE) (USOTC:OMHE)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Omni Health (CE) Charts.
Omni Health (CE) (USOTC:OMHE)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Omni Health (CE) Charts.